BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7581141)

  • 21. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful syngeneic transplantation using G-CSF-stimulated peripheral hematopoietic progenitor cells combined with post-transplant administration of G-CSF in a patient with acute lymphatic leukemia].
    Burkhard R; Schanz U; Gmür J
    Schweiz Med Wochenschr; 1996 Mar; 126(9):362-5. PubMed ID: 8701254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling.
    Ikegame K; Tanji Y; Kitai N; Tamaki H; Kawakami M; Fujioka T; Oka Y; Maruya E; Saji H; Sugiyama H; Ogawa H
    Bone Marrow Transplant; 2003 Mar; 31(6):507-10. PubMed ID: 12665848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning.
    Umeda K; Adachi S; Ishihara H; Higashi Y; Shiota M; Watanabe KI; Hishizawa M; Ichinohe T; Kitoh T; Maruya E; Saji H; Uchiyama T; Nakahata T
    Bone Marrow Transplant; 2003 Jun; 31(11):1061-3. PubMed ID: 12774061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful treatment of AML by HLA-compatible sibling umbilical cord blood stem cell transplantation--the first case report in China].
    Song Y; Wang G; Wan D
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):399-401. PubMed ID: 11721417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms.
    Fernández MN; Regidor C; Cabrera R; García-Marco J; Briz M; Forés R; Sanjuán I; McWhinnie A; Querol S; García J; Madrigal A
    Bone Marrow Transplant; 2001 Aug; 28(4):355-63. PubMed ID: 11571507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Umbilical cord blood as a good alternative to bone marrow for allogeneic cell transplantation in children with hemoblastosis.
    Díaz de Heredia C; Ortega JJ; Olivé T; Coll MT; Torrabadella M; Massuet L
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S80-2. PubMed ID: 9715899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated mismatched cord blood transplantation in an adult with secondary AML.
    Lambertengh Deliliers G; Soligo D; Della Volpe A; Bertolini F; Poli F; Romitti L; Tagliaferri E; Ibatici A; Onida F; Annaloro C; Gattinoni L; Sirchia G
    Bone Marrow Transplant; 1996 Aug; 18(2):469-72. PubMed ID: 8864467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
    Howrey RP; Martin PL; Driscoll T; Szabolcs P; Kelly T; Shpall EJ; Bearman SI; Slat-Vasquez V; Rubinstein P; Stevens CE; Kurtzberg J
    Bone Marrow Transplant; 2000 Dec; 26(11):1251-4. PubMed ID: 11149743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
    Carella AM; Lerma E; Dejana A; Corsetti MT; Celesti L; Bruni R; Benvenuto F; Figari O; Parodi C; Carlier P; Florio G; Lercari G; Valbonesi M; Casarino L; De Stefano F; Geniram A; Venturino M; Tedeschi L; Palmieri G; Piaggio G; Podestà M; Frassoni F; Van Lint MT; Marmont AM; Bacigalupo A
    Haematologica; 1998 Oct; 83(10):904-9. PubMed ID: 9830799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A; Piaggio G; Podesta M; Figari O; Benvenuto F; Sogno G; Tedone E; Raffo MR; Grassia L; Ferrero R
    Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cord blood stem cell transplantation for infantile acute lymphoblastic leukemia after primary cytomegalovirus infection].
    Goi K; Sugita K; Miyamoto N; Karakida N; Nakamura M; Kojika S; Iijima K; Kagami K; Nakazawa S
    Rinsho Ketsueki; 1997 Nov; 38(11):1229-33. PubMed ID: 9423343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.